Thomas G. Wiggans - 22 Sep 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
22 Sep 2025
Net transactions value
+$99,630
Form type
4
Filing time
24 Sep 2025, 16:01:57 UTC
Previous filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WIGGANS THOMAS G Director C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE #102, REDWOOD CITY /s/ Herb Cross, as Attorney-in-Fact 24 Sep 2025 0001208907

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JSPR Voting Common Stock Purchase $99,630 +41,000 $2.43 41,000 22 Sep 2025 By Wiggans Living Trust F1
holding JSPR Voting Common Stock 5,000 22 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Common Stock Warrant (right to buy) Purchase +41,000 41,000 22 Sep 2025 Voting Common Stock 41,000 $2.92 By Wiggans Living Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.